Peter Garcia
Overview
Peter Garcia received an average of $3M in total compensation, including $460K in salary, at ALX ONCOLOGY HOLDINGS between 2021 and 2022. Peter Garcia also received an average of $2M at PDL BioPharma from 2013 to 2019.
- 2022
- 2021
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
ALX ONCOLOGY HOLDINGSChief Financial Officer
ALX ONCOLOGY HOLDINGSChief Financial Officer
PDL BioPharmaFormer Vice President and Chief Financial Officer
PDL BioPharmaVice President and Chief Financial Officer
PDL BioPharmaVice President and Chief Financial Officer
PDL BioPharmaVice President and Chief Financial Officer
PDL BioPharmaVice President and Chief Financial Officer
PDL BioPharmaVice President and Chief Financial Officer
PDL BioPharmaVice President and Chief Financial Officer
Related executives
We found 19 more executives who work or worked at ALX ONCOLOGY HOLDINGS and PDL BioPharma.
Jaume Pons
ALX ONCOLOGY HOLDINGS
Chief Executive Officer
Sophia Randolph
ALX ONCOLOGY HOLDINGS
Chief Medical Officer
Dominique Monnet
PDL BioPharma
Chief Executive Officer
Christopher Stone
PDL BioPharma
General Counsel
Jill Jene
PDL BioPharma
Vice President, Business Development
Edward Imbrogno
PDL BioPharma
Chief Financial Officer
John McLaughlin
PDL BioPharma
Chief Executive Officer
Danny Hart
PDL BioPharma